HomeCompaniesProfile

WhiteLab Genomics

Unleashing the potential of DNA and RNA based therapies using AI 


Company Size

11 - 50 employees

Year Founded

2019


About WhiteLab Genomics

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

Share This Profile

More Companies

Interface Fund

Funding Breakthrough Talents

PrimeVault

Infrastructure powering stablecoin and digital finance

Clarion

The AI communication layer for healthcare

Anthropocene Ventures

Investing in pre and seed stage climate tech ​companies that leverage hard science and ​novel engineering to create a global economy ​more closely aligned with the earth’s ecology.

Vertis SGR

We deal with the investments of the innovative Made in Italy

Prime Ventures

Partners to the Visionaries

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.